Insulin
What is diabetes?
Diabetes is a disease in which your blood glucose, or blood sugar, levels are too high. Glucose comes from the foods you eat. The cells of your body need glucose for energy. A hormone called insulin helps the glucose get into your cells.
type 1 diabetestype 2 diabetesWhat are the treatments for diabetes?Treatments for diabetes can depend on the type. Common treatments include a diabetic meal plan, regular physical activity, and medicines. Some less common treatments are weight loss surgery for either type and an artificial pancreas or pancreatic islet transplantation for some people with type 1 diabetes.
Who needs diabetes medicines?People with type 1 diabetes need to take a diabetes medicine called insulin to control their blood sugar.
Some people with type 2 diabetes can control their blood sugar with healthy food choices and physical activity. But for others, a diabetic meal plan and physical activity are not enough. They need to take diabetes medicines.
The kind of medicine you take depends on your type of diabetes, daily schedule, medicine costs, and any other health conditions that you have. Over time, you may need to take more than one diabetes medicine.
What are the types of medicines for type 1 diabetes?If you have type 1 diabetes, you must take insulin because your body no longer makes it. There are different types of insulin that start to work at different speeds, and the effects of each last a different length of time. Your health care provider will measure your blood glucose to decide on the type of insulin. You may need to use more than one type.
You will also need to check your blood sugar at home. Your provider will tell you how often. The results of your blood sugar testing can help you make decisions about food, physical activity, and medicines.
You can take insulin several different ways. The most common are with a needle and syringe, an insulin pen, or an insulin pump. If you use a needle and syringe or a pen, you have to take insulin several times during the day, including with meals. An insulin pump gives you small, steady doses throughout the day. Less common ways to take insulin include inhalers, injection ports, and jet injectors.
In rare cases, taking insulin alone might not be enough to manage your blood sugar. Then you would need to take another diabetes medicine.
What are the types of medicines for type 2 diabetes?There are several different medicines for type 2 diabetes. Each works in a different way. Many of them are pills. There are also medicines that you inject under your skin, such as insulin.
Over time, you may need more than one diabetes medicine to manage your blood sugar. You might add another diabetes medicine or switch to a combination medicine. A combination medicine contains more than one type of diabetes medicine in the same pill. Some people with type 2 diabetes take both pills and injections.
Even if you don't usually take insulin, you may need it at special times, such as during pregnancy or if you are in the hospital.
What else should I know about taking medicines for diabetes?Even if you take medicines for diabetes, you still need to eat a healthy diet, stop smoking, take your other medicines, and get regular physical activity. These will help you manage your diabetes.
It is important to make sure that you understand your diabetes treatment plan. Talk to your provider about:
- What your target blood sugar level is
- What to do if your blood sugar gets too low or too high
- Whether your diabetes medicines will affect other medicines you take
- If you will have any side effects from the diabetes medicines
You should not change or stop your diabetes medicines on your own. Talk to your provider first.
NIH: National Institute of Diabetes and Digestive and Kidney Diseases
Insulin FDA Approved Drugs
- Method of reducing side effects of active components admin to a diabetic by admin a chemical compound having formula (incl pioglitazone) in combination with an insulin secretion enhancer.
- Administration of a composition comprising insulin complexed with a diketopiperazine..
- Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine..
- Administration of fdkp microparticles comprising insulin..
- Method of aerosolizing/deagglomerating an insulin dry powder for use in treating diabetes mellitus via oral inhalation using an inhaler with a cartridge containing the insulin dry powder..
- Method of controlling glycemia in diabetics by administering an initial dose of insulin-fdkp with a meal; determining blood glucose level 1-2 hrs after and administering a supplemental dose of insulin-fdkp if postprandial glucose level is >140 mg/dl.
- Method of delivering to a patient with diabetes mellitus in a single inhalation, greater than 75% of a dry powder dose comprising insulin and fumaryl diketopiperazine using a high resistance to flow dry powder inhaler..
- Pulmonary administration of a compisition comprising insulin bound to a diketopiperazine..
- Pulmonary administration of a composition comprising insulin bound to a complexing agent..
- Pulmonary administration of an insulin composition comprising fdkp at the beginning of a meal to a patient also being treated with a long-acting insulin..
- Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin..
- Treatment of diabetes mellitus with an inhaled insulin to improve glycemic control using a dry powder inhalation system comprising an inhaler, a cartridge and a dry powder medicament comprising insulin in a single inhalation.
- Treatment of patient having diabetes mellitus via oral inhalation of fdkp microparticles comprising insulin.
- Use of an inhaler to administer dry powder medicament.
- Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
- Method of treating a patient suffering from diabetes mellitus.
- Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
- Method of treating a patient suffering from diabetes mellitus.
- As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- Lowering plasma glucagon in a subject in need thereof, including one with type 2 diabetes, by administering an exendin or analog, such as exendin-4.
- Method for treating type 2 diabetes using a sustained-release composition containing exenatide.
- Reducing food intake in a subject with type 2 diabetes by administering an exendin, such as exendin-4.
- Reducing gastric motility or delaying gastric emptying by administering an exendin, such as exendin-4.
- Reductions in body weight are observed with exenatide.
- Treating type 2 diabetes mellitus with exenatide by stimulating insulin release.
- Treatment of type 2 diabetes.
- As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- Lowering plasma glucagon in a subject in need thereof, including one with type 2 diabetes, by administering an exendin or analog, such as exendin-4.
- Method for treating type 2 diabetes using a sustained-release composition containing exenatide.
- Reducing food intake in a subject with type 2 diabetes by administering an exendin, such as exendin-4.
- Reducing gastric motility or delaying gastric emptying by administering an exendin, such as exendin-4.
- Reductions in body weight are observed with exenatide.
- Treating type 2 diabetes mellitus with exenatide by stimulating insulin release.
- Treatment of type 2 diabetes.
- Lowering plasma glucagon in a subject in need thereof, including one with type 2 diabetes, by administering an exendin or analog, such as exendin-4.
- Reducing food intake in a subject with type 2 diabetes by administering an exendin, such as exendin-4.
- Reducing gastric motility or delaying gastric emptying by administering an exendin, such as exendin-4.
- Stimulating insulin release by administering exenatide.
- Treating type 2 diabetes mellitus with exenatide by stimulating insulin release.
- Use of exenatide may result in reduction in appetite..
- Use of exenatide may result in reduction in body weight.
- For chronic weight management for treating overweight or obesity.
- For effect on blood glucose parameters in patients with insulin resistance.
- Use of naltrexone and bupropion based on an escalating dose schedule.
- Use of naltrexone and bupropion for chronic weight management for treating overweight or obesity in patients with major depressive disorder.
- Use of naltrexone and bupropion in a layered formulation for chronic weight management for affecting weight loss.
- Use of naltrexone and bupropion in extended-release form for chronic weight management for treating overweight or obesity.
- Administration once daily within two hours after waking in the morning for improvement of glycemic control in a type 2 diabetes patient.
- Improvement of glycemic control in individuals with type 2 diabetes.
- Improvements of glycemic control in individuals with type 2 diabetes who have one or more specified cardiovascular risk factors.
- Treatment of type 2 diabetes by administering bromocriptine mesylate and a first-phase insulin secretagogue wherein the combined therapeutic effect is greater than the additive effect of administering each agent alone.
- Treatment of type 2 diabetes mellitus in a patient, wherein glycemic control (hba1c < 7.0%) is not achievable using one or more of insulin, metformin, pioglitazone, or rosiglitazone.
- Treatment of type 2 diabetes mellitus.
- Method of treating type 2 diabetes mellitus by administering linagliptin in combination with empagliflozin (with or without insulin or a sulfonylurea).
- Method of treating type 2 diabetes mellitus by administering linagliptin in combination with empagliflozin (with or without metformin).
- Method of treating type 2 diabetes mellitus by administering linagliptin in combination with empagliflozin and metformin.
- Method of treating type 2 diabetes mellitus by administering linagliptin in combination with empagliflozin.
Eli Lilly And CoMay 26, 2015
- Improvement of glycemic control in adults with type 2 diabetes mellitus.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with insulin.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with metformin and a ppar-gamma agonist.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
- Improvement of glycemic control in adults with type 2 diabetes mellitus in combination with metformin and/or a ppar-gamma agonist and/or sulfonylurea and/or insulin.
- Improvement of glycemic control in adults with type 2 diabetes mellitus in combination with metformin..
- Improvement of glycemic control in adults with type 2 diabetes mellitus.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with insulin.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with metformin and a ppar-gamma agonist.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with a ppar-gamma agonist.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and/or a sulfonylurea.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidaste-iv inhibitor.
- Method of treating diabetes comprising administering a compound such as alogliptin.
- Method of treating diabetes comprising administering alogliptin.
- Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
- Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
- Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
- Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
- Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
- Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
- Levemir is a long-acting basal insulin analog that is indicated in the treatment of patients with diabetes mellitus.
- Levemir is a long-acting basal insulin analog that is indicated in the treatment of patients with diabetes mellitus.
- Method of treating diabetes comprising administering a compound such as alogliptin.
- Method of treating diabetes comprising administering alogliptin.
- Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
- Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
- Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
- Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
- Method for treating type ii diabetes by administering saxagliptin.
- Method for treating type ii diabetes mellitus by administering saxagliptin alone or in combination with insulin, metformin, a thiazolidinedione, glyburide or metformin plus a sulfonylurea.
- Method of treating diabetes comprising administering a compound such as alogliptin.
- Method of treating diabetes comprising administering alogliptin.
- Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
- Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
- Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
- Methods of treating diabetes comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
- Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
- Improvement in glycemic control in adults with type 2 diabetes mellitus inadequately controlled by basal insulin or lixisenatide by use of a pen injector with a threaded drive sleeve.
- Treatment of diabetes with an amylin agonist, including with insulin.
- Treatment of diabetes with an amylin agonist.
- Use of an amylin agonist to reduce gastric motility and treat post prandial hypergylcemia.
- Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
- Improvement in glycemic control in diabetes mellitus patients.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with pioglitazone.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with sulfonlyurea.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and/or a sulfonylurea.
- Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidaste-iv inhibitor.
- Method of treating type 2 diabetes mellitus by administering linagliptin in combination with insulin (with or without metformin and/or pioglitazone).
- Method of treating type 2 diabetes mellitus by administering linagliptin in combination with metformin.
- Method of treating type 2 diabetes mellitus by administering linagliptin.
- Method of treating type 2 diabetes mellitus in patients with severe chronic renal impairment and for whom metformin therapy is inappropriate by administering linagliptin.
- Method of treating type 2 diabetes mellitus in patients with severe chronic renal impairment and who are ineligible for metformin therapy by administering linagliptin.
- Treatment of type 2 diabetes mellitus.
- Treatment of type 2 diabetes mellitus in a patient, wherein glycemic control (hba1c < 7.0%) is not achievable using one or more of insulin, metformin, pioglitazone, or rosiglitazone.
- Treatment of type 2 diabetes mellitus.